Bio Protocol vs LayerZero — how do they compare? Bio Protocol trades at Rp438.28 (market cap Rp982,11M, Rp157,98M 24h volume), while LayerZero trades at Rp13,840 (market cap Rp5,1T, Rp305,07M 24h volume). The key difference: LayerZero is far larger — about 5192.9× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 364M / 1B ZRO (37%) for LayerZero. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and LayerZero for 13 Days on average.
| BIO | ZRO | |
|---|---|---|
Market Cap | Rp982,11M | Rp5,1T |
Volume (24h) | Rp157,98M | Rp305,07M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 364M / 1B ZRO (37%) |
Typical Hold Time | 18 Days | 13 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
LayerZero (ZRO) is currently trading at Rp14,209 with a market cap of Rp5.16T, showing bearish technical signals as moving averages indicate strong selling pressure. The token trades near key support at Rp14,035 with neutral oscillators suggesting potential consolidation. With 37% of the 1 million token max supply in circulation and average hold time of 13 days, the asset shows moderate network participation.
Overall outlook remains cautious with technical indicators favoring sellers, though neutral RSI levels suggest potential stabilization. Key opportunities include protocol adoption growth, while risks include bearish momentum continuation and limited liquidity depth. Investors should monitor support levels closely for potential trend reversals.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →LayerZero is a blockchain interoperability protocol that connects various blockchains to support the development of omnichain applications and tokens. It employs immutable on-chain endpoints and a Security Stack, ensuring secure and censorship-resistant messaging across different blockchain networks.
Read more on ZRO →